VCNX: Vaccinex, Inc. Stock

by  •  • Comments Off on VCNX: Vaccinex, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.77
Enterprise Value ($M) 4.36
Book Value ($M) -2.49
Book Value / Share -0.93
Price / Book -1.52
NCAV ($M) -2.55
NCAV / Share -0.95
Price / NCAV -1.48

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.53
Return on Equity (ROE) -7.02

Liquidity (mrq)
Quick Ratio 0.50
Current Ratio 0.50

Balance Sheet (mrq) ($M)
Current Assets 2.53
Assets 2.60
Liabilities 5.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.60
Operating Income -18.73
Net Income -18.63
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -16.19
Cash from Investing -0.02
Cash from Financing 15.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -16.74
11-18 13D/A Zauderer Maurice 16.60 10.83
09-20 13D/A Fcmi Parent Co. 39.90 30.03

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
UCBJF – UCB SA UNBSF – Uni-Bio Science Group Limited
VAXX – Vaxxinity, Inc. VETOF – Vetoquinol SA
VGLS – VG Life Sciences Inc.


Financial data and stock pages provided by
Fintel.io